Yale University
New Haven, Connecticut, 06520, United States
NCT Number: NCT07221396
The goal of this study is to evaluate the feasibility, acceptability, and preliminary efficacy of a digital intervention called LDART in adults with stimulant use disorder.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
New Haven, Connecticut, 06520, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Let's Do Addiction Recovery Together! (LDART) is a web-based intervention grounded in social cognitive theory that is designed to reduce hazardous alcohol use. It has three active ingredients: 1) daily recovery goal setting and tracking, 2) motivational video, audio, and written messages from individuals in recovery, and 3) information on several community-based recovery groups (e.g., mutual-help groups, recovery community centers) that provide free, publicly available meetings and activities. Participants receive a text message reminder each night to go to the website to complete the activities, and a text message reminder each morning of the goal they set for themselves, with the option to change it. It only takes a few minutes to use LDART each day over the 4-week intervention period.
This is a 10-page PDF on stimulant use disorder created by the American Society of Addiction Medicine and American Academy of Addiction Psychiatry. It contains information about stimulant intoxication and withdrawal and treatment options. Participants will be encouraged to access this booklet for a few minutes each night over the 4-week intervention period.
Time frame: From enrollment to the final assessment time point (Day 56)
The percentage of eligible participants who are enrolled relative to the total number of eligible potential participants who completed the screening.
Time frame: From enrollment to the final assessment time point (Day 56)
The rate of enrollment, defined as number of participants enrolled per month.
Time frame: From enrollment to the final assessment time point (Day 56)
The percentage of enrolled participants who complete all study-related procedures (i.e., all three assessments).
Time frame: From beginning the intervention (Day 1) to the end of the intervention period (Day 28)
Number of nights enrolled participants completed the activities on the LDART website, out of 28 nights.
Time frame: The second assessment time point (post-intervention, Day 28)
Rating scores on the end-user version of the Mobile App Rating Scale (uMARS). Total score range 1-5 with higher scores indicating a better quality app.
Time frame: Baseline (Day 0), Post-intervention (Day 28), 1-month post-intervention (Day 56)
Change in self-reported number of days when any stimulants were used in the past 28 days, as measured using the Timeline Follow-back.
Time frame: Baseline (Day 0), Post-intervention (Day 28), 1-month post-intervention (Day 56)
Self-reported number of hours spent engaging with recovery groups in the past 28 days, as measured using a modified Timeline Follow-back
Yale University
Other
Pilot Study of the Digital Intervention LDART for Stimulant Use Disorder
Acronym: LDART
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04907357
Chemically-Induced Disorders, Cocaine Abuse
Winston-Salem, North Carolina, United States
View Trial DetailsNCT05610072
Chemically-Induced Disorders, Cocaine Use Disorder
Lexington, Kentucky, United States
View Trial DetailsNCT07490717
Chemically-Induced Disorders, Co-occurring Mental and Substance Use Disorders
Little Rock, Arkansas, United States
View Trial DetailsNCT06323837
Stimulant Use Disorder
Spokane, Washington, United States
View Trial Details